The results showed that the pathways significantly enriched (p < 0.05) in GY-RG compared with those in GY-CG were choline metabolism in cancer, retrograde endocannabinoid signaling, insulin resistance, and linoleic acid metabolism (Figure 3a). The gene discussed is INS; the disease is cancer.